We use a new genetics platform to develop better vaccines for flu, COVID-19, etc
Please include your email.
Huge global market for these vaccines: Universal flu - $22B; COVID-19 - $5B Chance to make an enormous societal impact Patented durable and universal flu vaccine Major smashes: Moderna, BioNTech, Novavax: Invest in the next one! Backed by Life Science Angels - #1 US angel group (CB Insights), Sand Hill Angels, Tech Coast Angels Funded by the DoD and the NSF
Arthur Young CEOPhD from a top 5-medical school, postdocs at Harvard and UCLA, pioneered a powerful new viral genetics platform, Olga Petrauskene DirectorProduced an HIV and flu diagnostic with Applied Biosystems that is sold in 60 countries, Justin Kern DirectorWrote a freelance article for Newsweek on vaccines that reached millions
Have you done enough research to provide a rating? This is important for your fellow investors.
We only allow one revision to each rating category. Be sure about any changes.
No reports have been submitted
Contact support@crowdlustro.com if you need assistance.
Your experience on this site will be improved by allowing cookies.